1
Pont, LG, Sturkenboom, MCJM, van Gilst, WH, Denig, P, Haaijer-Ruskamp, FM
Veröffentlicht in: Pont , LG , Sturkenboom , MCJM , van Gilst , WH , Denig , P & Haaijer-Ruskamp , FM 2003 , ' Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000 ' , Pharmacoepidemiology and Drug Safety , vol. 12 , no. 4 , pp. 327-334 . https://doi.org/10.1002/pds.809;
2003
Veröffentlicht in: Pont , LG , Sturkenboom , MCJM , van Gilst , WH , Denig , P & Haaijer-Ruskamp , FM 2003 , ' Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000 ' , Pharmacoepidemiology and Drug Safety , vol. 12 , no. 4 , pp. 327-334 . https://doi.org/10.1002/pds.809;
2003
2
Ramos, Isaac Corro, Versteegh, Matthijs M., de Boer, Rudolf A., Koenders, Jolanda M. A., Linssen, Gerard C. M., Meeder, Joan G., Rutten-van Molken, Maureen P. M. H.
Veröffentlicht in: Ramos , I C , Versteegh , M M , de Boer , R A , Koenders , J M A , Linssen , G C M , Meeder , J G & Rutten-van Molken , M P M H 2017 , ' Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands : A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines ' , Value in Health , vol. 20 , no. 10 , pp. 1260-1269 . https://doi.org/10.1016/j.jval.2017.05.013;
2017
Veröffentlicht in: Ramos , I C , Versteegh , M M , de Boer , R A , Koenders , J M A , Linssen , G C M , Meeder , J G & Rutten-van Molken , M P M H 2017 , ' Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands : A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines ' , Value in Health , vol. 20 , no. 10 , pp. 1260-1269 . https://doi.org/10.1016/j.jval.2017.05.013;
2017